- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02054650
OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Osteopathic Manipulative Treatment of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
SPECIFIC AIM 1:
To conduct a randomized controlled trial (RCT) to determine the efficacy of osteopathic manual treatment (OMT) vs sham OMT in subjects with type 2 diabetes mellitus (T2DM) and comorbid chronic low back pain (LBP). This will involve a 12-week protocol to study changes in response to OMT in such outcomes as LBP severity (primary outcome measure), somatic dysfunction, renal function, glycemic control, and other biomarkers potentially related to T2DM.
SPECIFIC AIM 2:
Within the RCT, to corroborate previous findings indicating that patients with T2DM have a high prevalence of tissue texture abnormalities in the T11-L2 spinal segmental region and to determine if such findings can be statistically associated with the presence of diabetic nephropathy using such laboratory measures as serum creatinine, urinary microalbuminuria and macroalbuminuria, and the glomerular filtration rate.
SPECIFIC AIM 3:
Within the RCT, to explore potential mechanisms of action of OMT by longitudinally measuring concentrations of biomarkers such as insulin, glucagon, cortisol, hemoglobin A1c, tumor necrosis factor-α,interleukin (IL)-1β, IL-6, IL-10, and IL-18 in subjects with T2DM and comorbid chronic LBP over 12 weeks. Significant changes in biomarker concentrations may help explain the effects of OMT and whether such effects are mediated by changes in somatic dysfunction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76107
- University of North Texas Health Science Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Fasting plasma glucose ≥126 mg/dL; OR
- Oral glucose tolerance test ≥200 mg/dL; OR
HbA1c ≥6.5%
AND
- Low back pain on most days for past three months; AND
- Usual low back pain severity of 4 or greater on an 11 point numerical scale during the past week.
Exclusion Criteria:
- age less than 18 years or age greater than 79 years; OR
- having a previous or current diagnosis of type 1 diabetes mellitus; OR
- having a history of any of the following pancreatic or related disorders: (a) acute or chronic pancreatitis, (b) pancreatic tumor or cancer, (c) Zollinger-Ellison syndrome, or (d) any other medical or surgical condition resulting in functional hypo- or hyperglycemia; OR
- having end-stage renal disease; OR
- having a history of any surgery involving the pancreas; OR
- having a history of low back surgery in the past year; OR
- receiving workers' compensation benefits in the past three months; OR
- having involvement in ongoing litigation relating to diabetes mellitus or back problems; OR
- having a history of a stroke or transient ischemic attack in the past year; OR
- having used intravenous, intramuscular or oral corticosteroids within the past month; OR
- attending a manual treatment session (OMT or any manual therapies delivered by chiropractors or physical therapists) in the past three months, or more than three times in the past year; OR
- practicing osteopathic medicine, chiropractic, or physical therapy, or attending a corresponding professional school; OR
- being pregnant; OR
- currently participating in another medical research study
Subjects will also be excluded if any of the following conditions are found during the clinical screening:
- presence of "red flag" conditions relating to LBP (cancer at any anatomical site, spinal osteomyelitis, spinal fracture, herniated disc, ankylosing spondylitis, or cauda equina syndrome); OR
- angina or congestive heart failure symptoms with minimal activity; OR
- active bleeding or infection in the lower back, or any other condition that might impede protocol implementation; OR
- discovery of the presence of any telephone screening exclusion criterion (EXCEPT that the usual LBP severity over the past week may have declined from ≥4/10 points to ≥3/10 points during the lag time between screenings).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Osteopathic Manual Treatment (OMT)
The OMT protocol will be delivered following an examination for somatic dysfunction at each treatment session.
The protocol will target the thoracic, lumbosacral, iliac, and pubic regions using the following techniques: high-velocity, low-amplitude thrusts; moderate-velocity, moderate-amplitude thrusts; soft tissue including stretching, kneading, and pressure; myofascial stretching and release; counterstrain; muscle energy; and other optional techniques as time permits and indicated.
The intervention will be delivered at weeks 0, 1, 2, 4, 6 and 8. Week 12 is a data collection visit with no intervention.
|
Osteopathic Manual Treatment (OMT) is a system of hands-on techniques used by osteopathic physicians to increase function and reduce pain.
|
SHAM_COMPARATOR: Sham OMT
Sham OMT will involve hand contact, active and passive range of motion, and sham techniques that simulate OMT (including optional OMT techniques), but that utilize such maneuvers as light touch, improper patient positioning, purposely misdirected movements, and diminished provider force.
Sham OMT will be delivered at weeks 0, 1, 2, 4, 6 and 8. Week 12 is a data collection visit with no intervention.
|
Sham OMT involves hand contact, active and passive range of motion, and sham techniques that simulate OMT, but that utilize such maneuvers as light touch, improper patient positioning, purposely misdirected movements, and diminished provider force.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in low back pain severity
Time Frame: 12 weeks
|
The change in low back pain severity will be measured using an 11-point numerical scale (0 to 10).
The baseline measurement for each subject will be compared with the week 12 measurement to determine if a reduction in pain has occurred.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in back-specific functioning
Time Frame: 12 weeks
|
The change in back-specific functioning will be measured using the Roland-Morris Disability Questionnaire (scored from 0 to 24).
The baseline measurement for each subject will be compared with the week 12 measurement to determine if an improvement in back-specific functioning has occurred.
|
12 weeks
|
Change in general health
Time Frame: 12 weeks
|
The change in general health will be measured using the Short Form 36 Health Status Survey (scored from 0 to 100).
The baseline measurement for each subject will be compared with the week 12 measurement to determine if an improvement in general health has occurred.
|
12 weeks
|
Change in glycemic control
Time Frame: 12 weeks
|
The change in glycemic control will be measured using hemoglobin A1C levels.
The baseline measurement for each subject will be compared with the week 12 measurement to determine if an improvement in glycemic control has occurred.
|
12 weeks
|
Tissue texture changes
Time Frame: 12 weeks
|
The change in tissue texture will be assessed during physical examinations.
The baseline findings for each subject will be compared with the week 12 findings to determine if a change in tissue texture has occurred.
|
12 weeks
|
Change in biomarker concentrations
Time Frame: 12 weeks
|
Concentrations of biomarkers such as insulin, glucagon, cortisol, TNF-α, IL-1β, IL-6, IL-10, and IL-18 will be measured at baseline and at week 12 to determine if any significant change in a biomarker has occurred.
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: John C. Licciardone, DO, MS, MBA, University of North Texas Health Science Center
Publications and helpful links
General Publications
- Licciardone JC, Kearns CM, Hodge LM, Minotti DE. Osteopathic manual treatment in patients with diabetes mellitus and comorbid chronic low back pain: subgroup results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2013 Jun;113(6):468-78.
- Licciardone JC, Kearns CM, Minotti DE. Outcomes of osteopathic manual treatment for chronic low back pain according to baseline pain severity: results from the OSTEOPATHIC Trial. Man Ther. 2013 Dec;18(6):533-40. doi: 10.1016/j.math.2013.05.006. Epub 2013 Jun 10.
- Licciardone JC, Minotti DE, Gatchel RJ, Kearns CM, Singh KP. Osteopathic manual treatment and ultrasound therapy for chronic low back pain: a randomized controlled trial. Ann Fam Med. 2013 Mar-Apr;11(2):122-9. doi: 10.1370/afm.1468.
- Licciardone JC, Kearns CM, Hodge LM, Bergamini MV. Associations of cytokine concentrations with key osteopathic lesions and clinical outcomes in patients with nonspecific chronic low back pain: results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2012 Sep;112(9):596-605. doi: 10.7556/jaoa.2012.112.9.596. Erratum In: J Am Osteopath Assoc. 2017 Jun 1;117(6):350.
- Licciardone JC, Kearns CM. Somatic dysfunction and its association with chronic low back pain, back-specific functioning, and general health: results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2012 Jul;112(7):420-8.
- Licciardone JC, Gatchel RJ, Kearns CM, Minotti DE. Depression, somatization, and somatic dysfunction in patients with nonspecific chronic low back pain: results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2012 Dec;112(12):783-91.
- Licciardone JC, Fulda KG, Stoll ST, Gamber RG, Cage AC. A case-control study of osteopathic palpatory findings in type 2 diabetes mellitus. Osteopath Med Prim Care. 2007 Feb 8;1:6. doi: 10.1186/1750-4732-1-6.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-127
- 13-11-686 (OTHER_GRANT: American Osteopathic Association)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
-
Newsoara Biopharma Co., Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus)China
Clinical Trials on Osteopathic Manual Treatment (OMT)
-
Studio Osteopatico Busto ArsizioRecruitingGastro-oesophageal Reflux DiseaseItaly
-
I.R.C.C.S. Fondazione Santa LuciaCompletedSpinal Cord InjuriesItaly
-
University of Wisconsin, MadisonCompletedOcular Hypertension | GlaucomaUnited States
-
A.T. Still University of Health SciencesAmerican Osteopathic AssociationRecruitingPost-Acute COVID-19 SyndromeUnited States
-
Fondazione Don Carlo Gnocchi OnlusCompleted
-
University of North Texas Health Science CenterOsteopathic Heritage FoundationsCompletedMusculoskeletal Diseases | Low Back Pain | Pregnancy ComplicationsUnited States
-
University of Milano BicoccaItalian School of Osteopathy and Manual Therapies; Alpha Search MilanoWithdrawnTension-Type Headache
-
Western University of Health SciencesRecruiting
-
Western University of Health SciencesAmerican College of Osteopathic Physicians; American Osteopathic Foundation; Osteopathic... and other collaboratorsRecruiting
-
Rowan UniversityAmerican Osteopathic AssociationCompletedLumbar Spinal Stenosis | Lumbar Radiculopathy | Lumbar Spondylosis | Lesion of Sciatic Nerve, Left Lower Limb | Lesion of Sciatic Nerve, Right Lower Limb | Lumbago With Sciatica, Left Side | Lumbago With Sciatica, Right SideUnited States